Your browser doesn't support javascript.
loading
The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesis.
Ikeda, Naoki; Kubota, Hiroaki; Suzuki, Risa; Morita, Mitsuki; Yoshimura, Ayana; Osada, Yuya; Kishida, Keigo; Kitamura, Daiki; Iwata, Ayaka; Yotsumoto, Satoshi; Kurotaki, Daisuke; Nishimura, Koutarou; Nishiyama, Akira; Tamura, Tomohiko; Kamatani, Takashi; Tsunoda, Tatsuhiko; Murakawa, Miyako; Asahina, Yasuhiro; Hayashi, Yoshihiro; Harada, Hironori; Harada, Yuka; Yokota, Asumi; Hirai, Hideyo; Seki, Takao; Kuwahara, Makoto; Yamashita, Masakatsu; Shichino, Shigeyuki; Tanaka, Masato; Asano, Kenichi.
Afiliação
  • Ikeda N; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Kubota H; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Suzuki R; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Morita M; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Yoshimura A; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Osada Y; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Kishida K; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Kitamura D; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Iwata A; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Yotsumoto S; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Kurotaki D; Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa 236-0004, Japan; Laboratory of Chromatin Organization in Immune Cell Development, International Research Center for Medical Sciences, Kumamoto University, Kumamoto 860-8555, Japan.
  • Nishimura K; Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa 236-0004, Japan.
  • Nishiyama A; Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa 236-0004, Japan.
  • Tamura T; Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa 236-0004, Japan.
  • Kamatani T; Laboratory for Medical Science Mathematics, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0032, Japan; Division of Precision Cancer Medicine, Tokyo Medical and Dental University, Tokyo 113-8519, Japan; Division of Pulmonary Medicine, Department of
  • Tsunoda T; Laboratory for Medical Science Mathematics, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0032, Japan; Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
  • Murakawa M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
  • Asahina Y; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan; Department of Liver Disease Control, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
  • Hayashi Y; Laoratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Harada H; Laoratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Harada Y; Department of Clinical Laboratory, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo 113-8677, Japan.
  • Yokota A; Laboratory of Stem Cells Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Hirai H; Laboratory of Stem Cells Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Seki T; Department of Biochemistry, Toho University School of Medicine, Tokyo 143-8540, Japan.
  • Kuwahara M; Department of Immunology, Graduate School of Medicine, Ehime University, Ehime 791-0295, Japan.
  • Yamashita M; Department of Immunology, Graduate School of Medicine, Ehime University, Ehime 791-0295, Japan.
  • Shichino S; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba 278-0022, Japan.
  • Tanaka M; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan. Electronic address: mtanaka@toyaku.ac.jp.
  • Asano K; Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan. Electronic address: asanok@toyaku.ac.jp.
Cell Rep ; 42(3): 112165, 2023 03 28.
Article em En | MEDLINE | ID: mdl-36862552
ABSTRACT
Inflammatory stimuli cause a state of emergency myelopoiesis leading to neutrophil-like monocyte expansion. However, their function, the committed precursors, or growth factors remain elusive. In this study we find that Ym1+Ly6Chi monocytes, an immunoregulatory entity of neutrophil-like monocytes, arise from progenitors of neutrophil 1 (proNeu1). Granulocyte-colony stimulating factor (G-CSF) favors the production of neutrophil-like monocytes through previously unknown CD81+CX3CR1lo monocyte precursors. GFI1 promotes the differentiation of proNeu2 from proNeu1 at the cost of producing neutrophil-like monocytes. The human counterpart of neutrophil-like monocytes that also expands in response to G-CSF is found in CD14+CD16- monocyte fraction. The human neutrophil-like monocytes are discriminated from CD14+CD16- classical monocytes by CXCR1 expression and the capacity to suppress T cell proliferation. Collectively, our findings suggest that the aberrant expansion of neutrophil-like monocytes under inflammatory conditions is a process conserved between mouse and human, which may be beneficial for the resolution of inflammation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monócitos / Neutrófilos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monócitos / Neutrófilos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article